Hellard ME, Pickles R, Fuller A, Spelman D; Australasian Society for HIV Medicine. Conference.
Annu Conf Australas Soc HIV Med. 1994 Nov 3-6; 6: 119 (unnumbered abstract).
Alfred Hospital, Melbourne.
Totally implantable central venous access devices (trade name--Infusaport [IFP]) are used increasingly in AIDS patients for home and inpatient therapy. This report reviews the number of IFP's implanted in patients from the Alfred Hospital Infectious Diseases Unit between January 1992 and June 1994, and the incidence and management of infections associated with these devices. Thirty-six patients had 47 IFP's implanted. There were a total of 12 IFP related infections in 9 patients. Infection was defined as: 1. Local infection--erythema, tenderness and induration with or without fever. 2. Tunnel infection. 3. Septicaemia. a) positive blood cultures drawn from the IFP, peripheral vein or both sites without an identifiable focus for the infection elsewhere. b) Presumed catheter sepsis where clinical signs of septicaemia are present despite multiple negative blood cultures, resolving within 72 hours of the device's removal. A wide variety of organisms was isolated, the most common being a coagulase negative Staphylococcus. All patients received intravenous antibiotics and 5 had antibiotic locks within the IFP. No infection fully resolved until the IFP device was removed. An update of this experience will be given.
Publication Types:
Keywords:
- Acquired Immunodeficiency Syndrome
- Anti-Bacterial Agents
- Catheters, Indwelling
- Communicable Diseases
- Fever
- Humans
- Incidence
- Infection
- Infusion Pumps, Implantable
- Sepsis
- instrumentation
Other ID:
UI: 102212261
From Meeting Abstracts